J&J on gainsharing
This article was originally published in The Gray Sheet
Executive Summary
CFO Robert Darretta tells investors during April 19 earnings call that the strategy by which some hospitals curb the cost of devices purchased - allowing doctors to share in the savings - is "something [the firm is] monitoring and, I am sure, we will have conversations about it in the future" (1"The Gray Sheet" April 11, 2005, p. 14). He added: "I am not sure about how [regulators] will feel about endorsing it [or] what length of time gains might be shared and among whom and how. Those things will have a significant impact on people's receptivity to the concept"...
You may also be interested in...
Ortho Firms Feel DoJ Probe Price As Stocks Fall In Q1; Will Zimmer Diversify?
The federal government's mounting scrutiny of orthopedic industry pricing practices for hip and knee replacement implants could convince Zimmer to more aggressively seek a presence in the artificial disc arena
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.